Governance

Resource
July 18, 2018

The global AIDS response is at a precarious point—partial success in saving lives and stopping new HIV infections is giving way to complacency. At the halfway point to the 2020 targets, the pace of progress is not matching the global ambition.

Opportunity
July 2, 2018

Through the TSP Program, Baylor-Swaziland and Baylor-Malawi are implementing the Supply Chain and Pharmaceutical Assistance for Sustainable Systems (SC+PASS) Project in eSwatini.

Event
July 2, 2018

Satellite Session at the 22nd International AIDS Conference 2018 (AIDS 2018)
RAI Amsterdam, the Netherlands
Wednesday, July 25, 2018 | 7:00-8:30 am | Conference Room E102

Resource
June 26, 2018
In our third issue, we have assembled 72 abstracts published from April through May 2018 that feature articles from Botswana (4), Lesotho (2), Malawi (7), Mozambique (5), South Africa (43), Swaziland (2), Tanzania (4), Zambia (2) and Zimbabwe (9).
Resource
June 26, 2018

This article is featured in the SHARE Research Digest. Click here to learn more.

Resource
June 25, 2018

In 2015, several condom manufacturers joined donor agencies to form a coalition whose main goal is to provide 20 billion condoms to low and middle-income countries by 2020.

Opportunity
June 25, 2018

The USAID-funded The Demographic and Health Survey (DHS) Program is searching for potential participants for a Regional Health Data Mapping Workshop. The workshop will be held from August 13-17, 2018 in South Africa. 

Resource
June 25, 2018

Start Free Stay Free AIDS Free is a collaborative framework to accelerate the end of the AIDS epidemic among children, adolescents and young women by 2020.

eToolkit
June 11, 2018

The HIV New Product Introduction Toolkit provides Ministries of Health (MoHs) and implementing partners with the tools necessary to evaluate the adoption and introduction of new products in their local context.

Resource
June 11, 2018

Over the past two decades, the landscape of medications used to treat HIV has evolved rapidly. Treatment options have improved dramatically with the development and availability of more efficacious, safer, and more tolerable antiretrovirals (ARVs).